NPORT-EX 2 70AZTRPInstIntCoreEqtyFd.htm trowepriceinstitutionalinter.htm - Generated by SEC Publisher for SEC Filing

T. ROWE PRICE INSTITUTIONAL INTERNATIONAL CORE EQUITY FUND
January 31, 2020 (Unaudited)

Portfolio of Investments  Shares  $ Value    Shares  $ Value 
(Cost and value in $000s)      (Cost and value in $000s)     
 
AUSTRALIA 4.1%      National Bank of Canada  4,203  233 
      Sun Life Financial  6,739  317 
 
Common Stocks 4.1%      Total Canada     
Australia & New Zealand Banking      (Cost $805)    1,026 
    Group  9,853  168       
 
BHP Group  2,041  52  CHILE 0.5%     
Challenger  24,259  144       
 
CSL  591  122  Common Stocks 0.5%     
IGO  33,164  134       
      Antofagasta (GBP)  13,750  148 
Macquarie Group  2,406  230       
Rio Tinto  1,240  80  Total Chile     
Scentre Group  41,596  107  (Cost $150)    148 
South32  56,216  96       
Telstra  17,705  45  CHINA 3.2%     
Worley  15,086  151       
      Common Stocks 3.2%     
Total Australia           
(Cost $1,095)    1,329  Alibaba Group Holding, ADR     
      (USD) (1)  1,075  222 
      Baidu, ADR (USD) (1)  606  75 
AUSTRIA 0.2%           
      Beijing Enterprises Holdings     
      (HKD)  20,500  90 
Common Stocks 0.2%      JOYY, ADR (USD) (1)  1,954  118 
Erste Group Bank  2,143  79  PICC Property & Casualty,     
Total Austria      H Shares (HKD)  192,000  205 
(Cost $72)    79  Ping An Insurance Group,     
      H Shares (HKD)  16,000  181 
      Tencent Holdings (HKD)  2,800  134 
BELGIUM 0.6%           
      Total China     
Common Stocks 0.6%      (Cost $707)    1,025 
Umicore  4,004  184       
      DENMARK 1.3%     
Total Belgium           
(Cost $94)    184       
      Common Stocks 1.3%     
      Ascendis Pharma, ADR (USD) (1)  451  61 
BRAZIL 0.1%           
      Danske Bank  7,542  126 
      GN Store Nord  2,612  129 
Common Stocks 0.1%           
      Novo Nordisk, B Shares  1,769  108 
XP, Class A (USD) (1)  786  32       
      Total Denmark     
Total Brazil      (Cost $372)    424 
(Cost $21)    32       
 
      FINLAND 1.0%     
CANADA 3.2%           
 
      Common Stocks 1.0%     
Common Stocks 3.2%           
      Sampo, A Shares  2,538  115 
Element Fleet Management  24,682  237       
Magna International (USD)  4,719  239       

 

The accompanying notes are an integral part of this Portfolio of Investments.


 

T. ROWE PRICE INSTITUTIONAL INTERNATIONAL CORE EQUITY FUND

  Shares  $ Value    Shares  $ Value 
(Cost and value in $000s)      (Cost and value in $000s)     
 
Stora Enso, R Shares  14,760  191  HONG KONG 1.3%     
Total Finland           
(Cost $240)    306  Common Stocks 1.3%     
      AIA Group  14,600  145 
FRANCE 9.1%      CK Hutchison Holdings  22,468  199 
      Samsonite International  44,700  83 
Common Stocks 9.1%      Total Hong Kong     
Air Liquide  1,555  225  (Cost $450)    427 
AXA  16,928  450       
BNP Paribas  5,487  291  IRELAND 0.5%     
Engie  18,199  313       
Eutelsat Communications  6,089  91  Common Stocks 0.5%     
Ipsen  1,158  86  DCC (GBP)  1,966  159 
Kering  329  201       
L'Oreal  1,066  297  Total Ireland     
      (Cost $104)    159 
Legrand  1,691  135       
Sanofi  3,540  341       
TOTAL  8,083  394  ITALY 1.7%     
Unibail-Rodamco-Westfield  676  92       
      Common Stocks 1.7%     
Total France           
(Cost $2,531)    2,916  Intesa Sanpaolo  51,588  128 
      Moncler  4,723  203 
      Prysmian  6,235  139 
GERMANY 8.8%      Telecom Italia  121,648  64 
 
Common Stocks 8.8%      Total Italy     
      (Cost $440)    534 
BASF  2,680  181       
Bayer  5,360  430       
Commerzbank  4,787  27  JAPAN 21.9%     
Covestro  2,513  106       
Deutsche Wohnen  2,946  125  Common Stocks 21.9%     
Evotec (1)(2)  2,782  75  Aisin Seiki  2,600  87 
Fresenius  4,730  242  Asahi Kasei  18,800  192 
Knorr-Bremse  1,148  125  Astellas Pharma  28,300  500 
Munich Re  1,310  386  Central Japan Railway  800  157 
Siemens  4,543  560  CyberAgent  3,400  135 
Siemens Healthineers  3,994  188  Electric Power Development  5,700  129 
Stroeer  1,371  109  Hamamatsu Photonics  3,200  135 
Telefonica Deutschland Holding  46,606  141  Honda Motor  3,200  82 
Zalando (1)  2,697  129  Kirin Holdings  4,900  108 
      Mitsubishi  7,900  203 
Total Germany           
(Cost $2,768)    2,824  Mitsubishi Electric  22,900  318 
      Mitsubishi UFJ Financial Group  43,700  224 
      Mitsubishi UFJ Lease & Finance  16,900  106 
      Mitsui Fudosan  10,100  267 
      Murata Manufacturing  2,800  159 
      Nippon Telegraph & Telephone  22,400  571 
 
The accompanying notes are an integral part of this Portfolio of Investments.       

 


 

T. ROWE PRICE INSTITUTIONAL INTERNATIONAL CORE EQUITY FUND

  Shares  $ Value    Shares  $ Value 
(Cost and value in $000s)      (Cost and value in $000s)     
 
Omron  2,500  143  Storebrand  23,927  184 
Otsuka Holdings  4,400  195  Total Norway     
Panasonic  15,500  154  (Cost $588)    672 
Pola Orbis Holdings  2,000  43       
Recruit Holdings  6,000  234  SINGAPORE 1.5%     
Renesas Electronics (1)  10,600  67       
Seven & i Holdings  6,000  230       
      Common Stocks 1.5%     
SMC  300  129       
SoftBank Group  2,500  101  DBS Group Holdings  7,500  138 
Sony  2,500  175  United Overseas Bank  10,800  201 
Stanley Electric  4,900  126  Wilmar International  50,400  144 
Sumitomo  19,700  293  Total Singapore     
Sumitomo Mitsui Trust Holdings  3,736  138  (Cost $402)    483 
Sumitomo Rubber Industries  5,600  62       
Suzuki Motor  3,600  165  SOUTH KOREA 1.8%     
Takeda Pharmaceutical, ADR           
    (USD)  3,974  76  Common Stocks 1.8%     
TechnoPro Holdings  1,300  86  KT  3,006  63 
THK  5,800  145  NAVER  629  94 
Tokio Marine Holdings  5,400  293  Samsung Electronics  9,347  433 
Tokyo Electron  900  198       
Tosoh  1,800  25  Total South Korea     
Toyota Motor  5,700  396  (Cost $307)    590 
Welcia Holdings  1,400  77       
Z Holdings  23,600  94  SWEDEN 2.3%     
Total Japan           
(Cost $5,678)    7,018  Common Stocks 2.3%     
      Autoliv, SDR  1,637  127 
      Elekta, B Shares  10,253  117 
NETHERLANDS 4.7%           
      LM Ericsson, B Shares  31,471  248 
      Svenska Handelsbanken,     
Common Stocks 4.7%          A Shares  24,502  240 
ABN AMRO Bank, CVA  9,267  161       
ASML Holding  1,008  283  Total Sweden     
      (Cost $793)    732 
ING Groep  22,046  240       
Koninklijke Philips  11,418  523       
NXP Semiconductors (USD)  2,279  289  SWITZERLAND 9.2%     
 
Total Netherlands      Common Stocks 9.2%     
(Cost $1,203)    1,496       
      ABB  10,358  241 
      Alcon (1)  1,357  80 
NORWAY 2.1%      GAM Holding (1)(2)  5,198  16 
      Nestle  9,362  1,033 
Common Stocks 2.1%      Novartis  6,766  639 
DNB  15,401  269  Roche Holding  2,019  677 
Equinor  12,141  219  Zurich Insurance Group  621  258 
      Total Switzerland     
      (Cost $2,253)    2,944 
The accompanying notes are an integral part of this Portfolio of Investments.       

 


 

T. ROWE PRICE INSTITUTIONAL INTERNATIONAL CORE EQUITY FUND

  Shares  $ Value    Shares   $ Value 
(Cost and value in $000s)      (Cost and value in $000s)       
 
TAIWAN 2.0%      WPP  17,135   213 
      Total United Kingdom       
Common Stocks 2.0%      (Cost $4,773)      5,255 
Largan Precision  1,000  155         
Taiwan Semiconductor      UNITED STATES 0.8%       
    Manufacturing  46,000  475         
 
Total Taiwan      Common Stocks 0.8%       
(Cost $287)    630  Broadcom  801   244 
 
      Total United States       
UNITED KINGDOM 16.4%      (Cost $68)      244 
 
Common Stocks 16.4%             
      SHORT-TERM INVESTMENTS 0.4%    
Amcor, CDI (AUD)  11,964  126         
ASOS (1)  3,458  140  Money Market Funds 0.4%       
Aviva  27,155  142  T. Rowe Price Government Reserve    
Barclays, ADR (USD)  3,565  31    Fund, 1.57% (3)(4)  126,745   127 
BHP Group  8,796  191         
      Total Short-Term Investments       
Burberry Group  5,931  152  (Cost $127)      127 
Close Brothers Group  1,526  29         
Compass Group  7,265  180         
      SECURITIES LENDING COLLATERAL 0.9%    
Diageo  6,593  261         
Direct Line Insurance Group  38,428  171  Investments in a Pooled Account through Securities Lending 
GlaxoSmithKline, ADR (USD)  7,304  342  Program with JPMorgan Chase Bank 0.9%    
Great Portland Estates  12,013  148  Short-Term Funds 0.9%       
Johnson Matthey  5,385  185         
Kingfisher  57,576  155  T. Rowe Price Short-Term Fund,       
      1.75% (3)(4)  29,754   297 
Lloyds Banking Group  287,039  214         
Meggitt  33,740  300  Total Investments in a Pooled Account through    
Melrose Industries  72,464  222  Securities Lending Program with JPMorgan    
National Grid  15,668  208  Chase Bank      297 
Persimmon  4,839  195  Total Securities Lending Collateral    
Prudential  8,370  149  (Cost $297)      297 
Royal Dutch Shell, Class B, ADR             
   (USD) (2)  4,935  263         
RSA Insurance Group  16,140  117  Total Investments in Securities  99.6 %  
Standard Chartered  16,128  134  (Cost $26,625)  $   31,901 
Unilever  11,876  708  Other Assets Less Liabilities 0.4%   127 
Vodafone Group, ADR (USD)  14,247  279  Net Assets 100%  $   32,028 

 

‡ Country classifications are generally based on MSCI categories or another unaffiliated third party data provider; Shares are
denominated in the currency of the country presented unless otherwise noted.
(1) Non-income producing
(2) All or a portion of this security is on loan at January 31, 2020.
(3) Seven-day yield
(4) Affiliated Companies
ADR American Depositary Receipts
AUD Australian Dollar

The accompanying notes are an integral part of this Portfolio of Investments.


 

T. ROWE PRICE INSTITUTIONAL INTERNATIONAL CORE EQUITY FUND

CDI  CHESS or CREST Depositary Interest 
CVA  Dutch Certificate (Certificaten Van Aandelen) 
GBP  British Pound 
HKD  Hong Kong Dollar 
SDR  Swedish Depositary Receipts 
USD  U. S. Dollar 

 

The accompanying notes are an integral part of this Portfolio of Investments.


 

T. ROWE PRICE INSTITUTIONAL INTERNATIONAL CORE EQUITY FUND

Affiliated Companies
($000s)

The fund may invest in certain securities that are considered affiliated companies. As defined by the 1940 Act, an affiliated company is one in
which the fund owns 5% or more of the outstanding voting securities, or a company that is under common ownership or control. The following
securities were considered affiliated companies for all or some portion of the three months ended January 31, 2020. Net realized gain (loss),
investment income, change in net unrealized gain/loss, and purchase and sales cost reflect all activity for the period then ended.

        Change in Net       
    Net Realized Gain    Unrealized      Investment 
Affiliate      (Loss)    Gain/Loss      Income 
T. Rowe Price Government Reserve Fund    $    $      $ 1 
T. Rowe Price Short-Term Fund                —++ 
Totals    $  —#  $      $ 1+ 
 
 
Supplementary Investment Schedule                 
    Value  Purchase  Sales      Value 
Affiliate    10/31/19  Cost  Cost      1/31/20 
T. Rowe Price Government Reserve Fund  $  171    ¤  ¤  $   127
T. Rowe Price Short-Term Fund    145    ¤  ¤      297
            $   424^ 

 

# Capital gain distributions from mutual funds represented $0 of the net realized gain (loss).
++ Excludes earnings on securities lending collateral, which are subject to rebates and fees.
+ Investment income comprised $1 of dividend income and $0 of interest income.
¤ Purchase and sale information not shown for cash management funds.
^ The cost basis of investments in affiliated companies was $424.

The accompanying notes are an integral part of this Portfolio of Investments.


 

T. ROWE PRICE INSTITUTIONAL INTERNATIONAL CORE EQUITY FUND
Unaudited
NOTES TO PORTFOLIO OF
INVESTMENTS

T. Rowe Price Institutional International Core Equity Fund (the fund) is registered under the Investment Company Act
of 1940 (the 1940 Act) as an open-end management investment company and follows accounting and reporting guidance
of the Financial Accounting Standards Board Accounting Standards Codification Topic 946. The accompanying Portfolio
of Investments was prepared in accordance with accounting principles generally accepted in the United States of America
(GAAP). For additional information on the fund’s significant accounting policies and investment related disclosures,
please refer to the fund’s most recent semiannual or annual shareholder report and its prospectus.

VALUATION

The fund’s financial instruments are valued at the close of the New York Stock Exchange (NYSE), normally 4 p.m. ET,
each day the NYSE is open for business.

Fair Value
The fund’s financial instruments are reported at fair value, which GAAP defines as the price that would be received to
sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement
date. The T. Rowe Price Valuation Committee (the Valuation Committee) is an internal committee that has been
delegated certain responsibilities by the fund’s Board of Directors (the Board) to ensure that financial instruments are
appropriately priced at fair value in accordance with GAAP and the 1940 Act. Subject to oversight by the Board, the
Valuation Committee develops and oversees pricing-related policies and procedures and approves all fair value
determinations. Specifically, the Valuation Committee establishes procedures to value securities; determines pricing
techniques, sources, and persons eligible to effect fair value pricing actions; oversees the selection, services, and
performance of pricing vendors; oversees valuation-related business continuity practices; and provides guidance on
internal controls and valuation-related matters. The Valuation Committee reports to the Board and has representation
from legal, portfolio management and trading, operations, risk management, and the fund’s treasurer.

Various valuation techniques and inputs are used to determine the fair value of financial instruments. GAAP
establishes the following fair value hierarchy that categorizes the inputs used to measure fair value:

Level 1 - quoted prices (unadjusted) in active markets for identical financial instruments that the fund can access at
the reporting date

Level 2 - inputs other than Level 1 quoted prices that are observable, either directly or indirectly (including, but not
limited to, quoted prices for similar financial instruments in active markets, quoted prices for identical or
similar financial instruments in inactive markets, interest rates and yield curves, implied volatilities, and
credit spreads)

Level 3 - unobservable inputs

Observable inputs are developed using market data, such as publicly available information about actual events or
transactions, and reflect the assumptions that market participants would use to price the financial instrument.
Unobservable inputs are those for which market data are not available and are developed using the best information
available about the assumptions that market participants would use to price the financial instrument. GAAP requires
valuation techniques to maximize the use of relevant observable inputs and minimize the use of unobservable inputs.
When multiple inputs are used to derive fair value, the financial instrument is assigned to the level within the fair value
hierarchy based on the lowest-level input that is significant to the fair value of the financial instrument. Input levels are
not necessarily an indication of the risk or liquidity associated with financial instruments at that level but rather the
degree of judgment used in determining those values.

Valuation Techniques
Equity securities listed or regularly traded on a securities exchange or in the over-the-counter (OTC) market are valued
at the last quoted sale price or, for certain markets, the official closing price at the time the valuations are made. OTC
Bulletin Board securities are valued at the mean of the closing bid and asked prices. A security that is listed or traded on


 

T. ROWE PRICE INSTITUTIONAL INTERNATIONAL CORE EQUITY FUND

more than one exchange is valued at the quotation on the exchange determined to be the primary market for such
security. Listed securities not traded on a particular day are valued at the mean of the closing bid and asked prices for
domestic securities and the last quoted sale or closing price for international securities.

For valuation purposes, the last quoted prices of non-U.S. equity securities may be adjusted to reflect the fair value of
such securities at the close of the NYSE. If the fund determines that developments between the close of a foreign market
and the close of the NYSE will affect the value of some or all of its portfolio securities, the fund will adjust the previous
quoted prices to reflect what it believes to be the fair value of the securities as of the close of the NYSE. In deciding
whether it is necessary to adjust quoted prices to reflect fair value, the fund reviews a variety of factors, including
developments in foreign markets, the performance of U.S. securities markets, and the performance of instruments
trading in U.S. markets that represent foreign securities and baskets of foreign securities. The fund may also fair value
securities in other situations, such as when a particular foreign market is closed but the fund is open. The fund uses
outside pricing services to provide it with quoted prices and information to evaluate or adjust those prices. The fund
cannot predict how often it will use quoted prices and how often it will determine it necessary to adjust those prices to
reflect fair value. As a means of evaluating its security valuation process, the fund routinely compares quoted prices, the
next day’s opening prices in the same markets, and adjusted prices.

Actively traded equity securities listed on a domestic exchange generally are categorized in Level 1 of the fair value
hierarchy. Non-U.S. equity securities generally are categorized in Level 2 of the fair value hierarchy despite the
availability of quoted prices because, as described above, the fund evaluates and determines whether those quoted prices
reflect fair value at the close of the NYSE or require adjustment. OTC Bulletin Board securities, certain preferred
securities, and equity securities traded in inactive markets generally are categorized in Level 2 of the fair value
hierarchy.

Investments denominated in foreign currencies are translated into U.S. dollar values each day at the prevailing exchange
rate, using the mean of the bid and asked prices of such currencies against U.S. dollars as quoted by a major bank.

Investments in mutual funds are valued at the mutual fund’s closing NAV per share on the day of valuation and are
categorized in Level 1 of the fair value hierarchy.

Thinly traded financial instruments and those for which the above valuation procedures are inappropriate or are
deemed not to reflect fair value are stated at fair value as determined in good faith by the Valuation Committee. The
objective of any fair value pricing determination is to arrive at a price that could reasonably be expected from a current
sale. Financial instruments fair valued by the Valuation Committee are primarily private placements, restricted
securities, warrants, rights, and other securities that are not publicly traded.

Subject to oversight by the Board, the Valuation Committee regularly makes good faith judgments to establish and
adjust the fair valuations of certain securities as events occur and circumstances warrant. For instance, in determining
the fair value of an equity investment with limited market activity, such as a private placement or a thinly traded public
company stock, the Valuation Committee considers a variety of factors, which may include, but are not limited to, the
issuer’s business prospects, its financial standing and performance, recent investment transactions in the issuer, new
rounds of financing, negotiated transactions of significant size between other investors in the company, relevant market
valuations of peer companies, strategic events affecting the company, market liquidity for the issuer, and general
economic conditions and events. In consultation with the investment and pricing teams, the Valuation Committee will
determine an appropriate valuation technique based on available information, which may include both observable and
unobservable inputs. The Valuation Committee typically will afford greatest weight to actual prices in arm’s length
transactions, to the extent they represent orderly transactions between market participants, transaction information can
be reliably obtained, and prices are deemed representative of fair value. However, the Valuation Committee may also
consider other valuation methods such as market-based valuation multiples; a discount or premium from market value
of a similar, freely traded security of the same issuer; or some combination. Fair value determinations are reviewed on a
regular basis and updated as information becomes available, including actual purchase and sale transactions of the
issue. Because any fair value determination involves a significant amount of judgment, there is a degree of subjectivity


 

T. ROWE PRICE INSTITUTIONAL INTERNATIONAL CORE EQUITY FUND

inherent in such pricing decisions, and fair value prices determined by the Valuation Committee could differ from
those of other market participants. Depending on the relative significance of unobservable inputs, including the
valuation technique(s) used, fair valued securities may be categorized in Level 2 or 3 of the fair value hierarchy.

Valuation Inputs
The following table summarizes the fund’s financial instruments, based on the inputs used to determine their fair values
on January 31, 2020 (for further detail by category, please refer to the accompanying Portfolio of Investments):

($000s)    Level 1    Level 2    Level 3    Total Value 
Assets                 
Common Stocks  $  2,271  $  29,206  $    $  31,477 
Short-Term Investments    127            127 
Securities Lending Collateral    297            297 
Total  $  2,695  $  29,206  $    $  31,901